US4629689A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Binding assay with amplified read-out and gas-phase detection
Assignee: Honeywell International Inc
•
Filing: 1984-08-29
•
Granted: 1986-12-16
•
Expires: 2004-08-29
Abstract
Abstract At the conclusion of a selective binding assay (e.g., immunological or nucleic acid), an enzyme is present in modulated concentration and/or activity to moderate a chemical reaction such as the cleavage of o-nitrophenyl- beta -D-galactopyranoside. After a controlled period, the enzymatic product is transferred to the gas phase and concentrated relative to other components in the enzymatic reaction mixture, such as by extraction into ethyl ether, injection into a gas chromatography column and detection by flame ionization or electron capture. Kits for such assays are also disclosed.
Inventors
- 👤 Steven E. Diamond
- 👤 Francis J. Regina
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 05:42
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6816; C12Q1/6823; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/536; G01N33/542; Y; Y10; Y10S; Y10S435/00; Y10S435/803; Y10S435/807; Y10S435/81; Y10S435/975; Y10S436/00; Y10S436/807; Y10S436/808; Y10S436/825; Y10T; Y10T436/00; Y10T436/14; Y10T436/142222; Y10T436/143333
Claims Analysis
Total Claims: 32
Claim 1
Independent Claim
160 words
A method for the determination of a target selective binding pair member in a biological fluid sample comprising the steps: (a) performing a specific reaction for the target selective binding pair member in the biological fluid sample to form a first liquid phase; (b) providing a reaction moderating enzymatic moiety bound to a binding pair member in the first liquid phase, the concentration or activity of the reaction moderating enzymatic moiety being a function of the amount of target selective binding pair member participating in the specific binding reaction; (c) providing in contact with the first phase, a precursor convertible by chemical reaction moderated by the reaction moderating enzymatic moiety into a detectable moiety in a volatile form; (d) transferring into a gaseous phase the detectable moiety formed from the precursor; (e) concentrating the detectable moiety relative to other components of the first phase; and (f) detecting the detectable moiety which has been concentrated and transferred into the gaseous phase.
Claim 2
Independent Claim
160 words
A method for the determination of a target selective binding pair member in a biological fluid sample comprising the steps: (a) performing a specific reaction for the target selective binding pair member in the biological fluid sample to form a first liquid phase; (b) providing a reaction moderating enzymatic moiety bound to a binding pair member in the first liquid phase, the concentration or activity of the reaction moderating enzymatic moiety being a function of the amount of target selective binding pair member participating in the specific binding reaction; (c) providing in contact with the first phase, a precursor convertible by chemical reaction moderated by the reaction moderating enzymatic moiety into a detectable moiety in a volatile form; (d) transferring into a gaseous phase the detectable moiety formed from the precursor; (e) concentrating the detectable moiety relative to other components of the first phase; and (f) detecting the detectable moiety which has been concentrated and transferred into the gaseous phase.
Claim 3
Dependent Claim
29 words
The method of claim 1 wherein the target binding member is an antigen and the specific binding reaction is the binding of an antibody to the target binding member.
Claim 4
Dependent Claim
29 words
The method of claim 1 wherein the target binding member is a hapten and the specific binding reaction is the binding of an antibody to the target binding member.
Claim 5
Dependent Claim
29 words
The method of claim 1 wherein the target binding member is an antibody and the specific binding reaction is the binding of an antigen to the target binding member.
Claim 6
Dependent Claim
30 words
The method of claim 1 wherein the target binding member is a polynucleotide and the specific binding reaction is the binding of a complementary polynucleotide to the target binding member.
Claim 7
Dependent Claim
45 words
The method of claim 5 wherein the complementary polynucleotide is provided as a reagent complex of complementary polynucleotide bound to a labeled polynucleotide, and the labeled polynucleotide is displaced from the reagent complex by the binding of target selective binding pair member to complementary polynucleotide.
Claim 8
Dependent Claim
19 words
The method of claim 6 wherein the labeled polynucleotide is bound, directly or indirectly to the reaction moderating moiety.
Claim 9
Dependent Claim
13 words
The method of claim 7 wherein the reaction moderating moiety is an enzyme.
Claim 10
Dependent Claim
13 words
The method of claim 5 wherein the reaction moderating moiety is an enzyme.
Claim 11
Dependent Claim
13 words
The method of claim 1 wherein the reaction moderating moiety is an enzyme.
Claim 12
Dependent Claim
44 words
The method of claim 1 wherein the precursor is a substantially non-volatile conjugate containing a linkage cleavable by chemical reaction moderated by the reaction moderating moiety and containing the detectable moiety, with cleavage of the linkage releasing the detectable moiety in a volatile form.
Claim 13
Dependent Claim
20 words
The method of claim 11 wherein the linkage is selected from the group consisting of acetal, ester and amide linkages.
Claim 14
Dependent Claim
19 words
The method of claim 12 wherein the conjugate contains a sugar bound by the linkage to the detectable moiety.
Claim 15
Dependent Claim
10 words
The method of claim 13 wherein the sugar is monosaccharide.
Claim 16
Dependent Claim
20 words
The method of claim 14 wherein the monosaccharide is selected from the group consisting of glucose, galactose, fructose and mannose.
Claim 17
Dependent Claim
33 words
The method of claim 12 wherein the detectable moiety is a substituted phenyl with the linkage bound to a ring carbon and at least one other ring carbon has halo or nitro substituent.
Claim 18
Dependent Claim
15 words
The method of claim 11 wherein the detectable moiety contains a halo or nitro substituent.
Claim 19
Dependent Claim
35 words
The method of claim 1 wherein the transferring step (d) comprises extracting the detectable moiety from an aqueous liquid phase into an organic liquid phase and evaporating the detectable moiety from the organic liquid phase.
Claim 20
Dependent Claim
27 words
The method of claim 1 wherein the transferring step (d) comprises evaporating the detectable moiety from an aqueous liquid phase in which the conjugate has been cleaved.
Claim 21
Dependent Claim
29 words
The method of claim 1 wherein the detecting step (f) comprises subjecting the gaseous phase to electrons and determining electrons captured in the gaseous phase by the detectable moiety.
Claim 22
Dependent Claim
31 words
The method of claim 1 wherein the concentrating step (e) and detecting step (f) comprises ionizing the detectable moiety and determining the mobility of the detectable moiety in an electromagnetic field.
Claim 23
Dependent Claim
42 words
The method of claim 1 wherein the evaporating step (d), concentrating step (e) and detecting step (f) comprise entraining the detectable moiety in a gaseous stream of carrier gas and determining the migration of the detectable moiety through a gas chromatographic column.
Claim 24
Dependent Claim
20 words
The method of claim 22 wherein the detectable moiety migrated through the gas chromatographic column is determined by electron capture.
Claim 25
Dependent Claim
15 words
The method of claim 23 wherein the detectable moiety contains a nitro or halo substituent.
Claim 26
Dependent Claim
98 words
A diagnostic kit comprising: (a) a first reagent comprising an enzyme conjugated to a specific binding pair member capable of competing with the target binding pair member in a specific binding reaction, (b) a non-volatile conjugate containing a linkage clevable by chemical reaction catalyzed by the enzyme and containing a detectable moiety released in a volatile form from the conjugate upon cleavage of the linkage by the enzyme, (c) means for concentrating and transferring the detectable moiety to a gas phase, and (d) means for detecting detectable moiety which has been concentrated and transferred to the gas phase.
Claim 27
Dependent Claim
98 words
A diagnostic kit comprising: (a) a first reagent comprising an enzyme conjugated to a specific binding pair member capable of competing with the target binding pair member in a specific binding reaction, (b) a non-volatile conjugate containing a linkage clevable by chemical reaction catalyzed by the enzyme and containing a detectable moiety released in a volatile form from the conjugate upon cleavage of the linkage by the enzyme, (c) means for concentrating and transferring the detectable moiety to a gas phase, and (d) means for detecting detectable moiety which has been concentrated and transferred to the gas phase.
Claim 28
Dependent Claim
24 words
The diagnostic kit of claim 25 wherein the conjugate is a sugar bound by an acetal, ester is amide linkage to the detectable moiety.
Claim 29
Dependent Claim
12 words
The diagnostic kit of claim 26 wherein the sugar is a monosaccharide.
Claim 30
Dependent Claim
34 words
The diagnostic kit of claim 26 wherein the detectable moiety is a phenyl with the linkage bound to a ring carbon and at least one other ring carbon has a halo or nitro substitutent.
Claim 31
Dependent Claim
26 words
The diagnostic kit of claim 25 wherein the detectable moiety includes a halo or nitro substituent and the means for detecting is an electron capture detector.
Claim 32
Dependent Claim
16 words
The diagnostic kit of claim 25 wherein the means for separating comprises a gas chromatography column.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-12-15 | 1990-06-16 | 1990-12-16 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-12-15 | 1994-06-16 | 1994-12-16 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-12-15 | 1998-06-16 | 1998-12-16 | $7700.00 | Window Closed / Lapsed |